Imbio PHA (4.0.0) vs AI-Rad Companion (Cardiovascular)
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if your primary need is rapid, automated assessment of right ventricular dilation and risk stratification for pulmonary embolism and hypertension. This tool is specifically designed to analyze CT pulmonary angiogram (CTPA) scans, providing crucial RV/LV and PA/Ao ratios to quickly identify cardiac strain related to acute pulmonary issues.
View Imbio PHA (4.0.0) →Choose AI-Rad Companion (Cardiovascular) if…
Choose AI-Rad Companion (Cardiovascular) if you require a broader, multi-faceted AI-powered analysis for comprehensive cardiovascular disease evaluation. This solution excels at quantifying coronary calcium volume, segmenting and measuring the thoracic aorta according to medical guidelines, and providing detailed heart volume measurements, making it ideal for assessing chronic cardiovascular risk and structural heart health.
View AI-Rad Companion (Cardiovascular) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | AI-Rad Companion (Cardiovascular) |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing |
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Cloud-based (via teamplay digital health platform) and Edge deployment |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio PHA (4.0.0)Tool A emphasizes a rapid, fully-automated assessment typically completed in minutes, and aims to provide full quantitative analysis and 3D visualization without requiring added work from physicians. Its automated workflows allow images to be sent directly from the scanner to the algorithm and then to PACS without altering the normal workflow.
Clinical Value
AI-Rad Companion (Cardiovascular)While Tool A offers specialized assessment for pulmonary embolism and hypertension risk stratification using critical RV/LV and PA/Ao ratios, Tool B provides a broader range of quantitative and qualitative analyses for general cardiovascular diseases. This includes automatic recognition and quantification of coronary calcium volume, 3D overview and segmentation of the thoracic aorta, and heart volume measurement, offering wider applicability in a general cardiology setting.
Pricing & Value
TieBoth tools explicitly state 'contact for pricing' or 'contact vendor for pricing' in their published specifications. Without any publicly available pricing information or details on their value propositions, it is not possible to conduct a head-to-head comparison on this dimension.
Enterprise Readiness
Imbio PHA (4.0.0)Both tools are FDA-cleared and HIPAA compliant. However, Tool A explicitly offers 'Enterprise (on-premise)' deployment options, which is crucial for many large healthcare systems, alongside cloud and partner deployments. Furthermore, Tool A highlights its HIPAA compliance as 'third-party certified by compliancy group', providing an additional layer of assurance.
Innovation
AI-Rad Companion (Cardiovascular)Both tools leverage AI for automated image analysis. Tool A focuses on specialized algorithms within the cardiothoracic space. Tool B, from Siemens Healthineers, benefits from extensive clinical datasets for algorithm training and is part of a broader 'AI-Rad Companion' platform with plans for additional intelligent assistants, suggesting a more expansive and continuously evolving innovation strategy.
Support & Docs
AI-Rad Companion (Cardiovascular)Tool A provides clear contact information for support and lists user manuals for various versions and regions, along with an FAQ section. Tool B, from a large enterprise like Siemens Healthineers, offers a comprehensive 'Support & Documentation' section and an 'Academy' with extensive online training, workflow integration resources, and DICOM Conformance Statements, indicating a more robust and structured support ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | AI-Rad Companion (Cardiovascular) |
|---|---|---|
| Name | Imbio PHA (4.0.0) | AI-Rad Companion (Cardiovascular) |
| Company | Imbio | Siemens Medical Solutions U. |
| Description Summary | AI-powered medical image processing software for measuring cardiac structures from CTPA scans to assess potential right ventricular dilation and aid in diagnosis and risk stratification of pulmonary embolism and hypertension. | AI-powered image processing software providing quantitative and qualitative analysis of CT DICOM images to support physicians in evaluating cardiovascular diseases. |
| Ventricular & Pulmonary Artery Measurements | Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios. | Segmentation and volume measurement of the heart. |
| Aorta Analysis | Automated measurement of main pulmonary artery and aorta diameters; Calculates PA/Ao ratios. | Automatic 3D overview and segmentation of the thoracic aorta; Measurement of relevant aorta diameters based on medical guidelines and detected anatomical landmarks; Threshold-based highlighting of enlarged aorta diameters. |
| Coronary Calcium Quantification | Not specified | Automatic recognition and quantification of coronary calcium volume from CT images. |
| Report Format | Summary reports in PDF format; Generates annotated DICOM images. | Standardized, reproducible, and quantitative reports (DICOM SC format). |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and AI-Rad Companion (Cardiovascular).